DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DexCom and other ETFs, options, and stocks.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Kevin Ronald Sayer
CEOKevin Ronald Sayer
Employees
9,600
Employees9,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
9,600
Employees9,600

DXCM Key Statistics

Market cap
52.24B
Market cap52.24B
Price-Earnings ratio
84.80
Price-Earnings ratio84.80
Dividend yield
Dividend yield
Average volume
1.92M
Average volume1.92M
High today
$132.22
High today$132.22
Low today
$130.16
Low today$130.16
Open price
$131.72
Open price$131.72
Volume
2.28M
Volume2.28M
52 Week high
$142.00
52 Week high$142.00
52 Week low
$74.75
52 Week low$74.75

DXCM News

Yahoo Finance 3d
Reasons to Retain DexCom Stock in Your Portfolio Now - Yahoo Finance

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A robust first-quarter 2024 performance, along with...

Reasons to Retain DexCom Stock in Your Portfolio Now - Yahoo Finance
Yahoo Finance 3d
Insider Sale: EVP Strategy and Corporate Development Matthew Dolan Sells Shares of DexCom Inc - Yahoo Finance

Matthew Dolan, Executive Vice President of Strategy and Corporate Development at DexCom Inc (NASDAQ:DXCM), sold 2,423 shares of the company on May 15, 2024. The...

Insider Sale: EVP Strategy and Corporate Development Matthew Dolan Sells Shares of DexCom Inc - Yahoo Finance
Yahoo Finance 6d
Frank Sands' Strategic Moves in Q1 2024: A Closer Look at DexCom Inc's Portfolio Impact - Yahoo Finance

Insights into Sands Capital Management's Latest 13F Filing Frank M. Sands, Jr., CFA, the CEO and CIO of Sands Capital Management, has a distinguished career in...

Frank Sands' Strategic Moves in Q1 2024: A Closer Look at DexCom Inc's Portfolio Impact - Yahoo Finance

Analyst ratings

88%

of 25 ratings
Buy
88%
Hold
12%
Sell
0%

More DXCM News

Investor's Business Daily 7d
Stocks Showing Improved Relative Strength: DexCom - Investor's Business Daily

The Relative Strength (RS) Rating for DexCom (DXCM) moved up into a higher percentile Monday, as it got a lift from 68 to 71. X IBD's proprietary rating tracks...

Stocks Showing Improved Relative Strength: DexCom - Investor's Business Daily
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.